David C. Norris 🇺🇦 🗽
Dose Titration Algorithm Tuning #DTAT #DoseIndividualization #epistemology #philsci #MedicalResearch #oncology #ClinicalTrials #DoseFinding #fedi22 (he/him)
Reading a paper this morning https://onlinelibrary.wiley.com/doi/10.1002/pds.4295 that follows Nosek & Errington (2017) https://elifesciences.org/articles/23383.pdf in muddling the distinction between #replicability as a broader scientific aim vs #reproducibility as captured in the narrow (purely 'computational') idea of #reproducibleresearch discussed e.g. in a #Guix context here https://guix.gnu.org/cookbook/en/html_node/Reproducible-Research.html.
This mistake is not uncommon, and leads (in this present paper, at least) to insufficient stress on computational reproducibility as a sine qua non of any higher-order quality attribute.
Would anyone have advice on FOSS tooling for reproducible biomedical literature searches? What I'd want to do specifically is to document the *absence* of case reports of exceptional responses to drugs that got FDA accelerated approval. (As for why, see https://osf.io/59sya/files/q6trp.) These would start with automated searches of EuropePMC, then annotation of manual review results. Since a new case report could be published at any time, I would need these to be update-able. I'm guessing an approach built on #orgmode #make and other #root technologies could work well. @lukascbossert@mastodon.social @jameshowell@fediscience.org
#reproducibleresearch
"Market associations, religious welfare networks, professional guilds, neighbourhood councils – these exist everywhere in Pakistan, self-financed and genuinely representative of those they serve.
Somehow, donors never found them. Or rather, they looked right past them. What donors funded instead, quite generously, were those groups established specifically to attract their money."
https://www.theguardian.com/global-development/2026/may/16/aid-programmes-donors-pakistan-ngos-civil-society
#civilsociety
